Cancer treatment alters mutant selection in normal esophagus

More on TP53

• Germline HRD limits therapy-driven clonal hematopoiesis

  Nature Genetics · 4 Oct 2026

• Y chromosome loss linked to advanced pancreatic cancer

  bioRxiv · 7 Oct 2026

  

• Blind mole-rat mesenchymal stem cells resist carcinogen-induced damage through preserved p53 signaling

  Stem Cells · 3 Oct 2026

  

• Single-neuron sequencing reveals widespread low-frequency somatic mutations in dementia brains

  bioRxiv · 2 Oct 2026